EUVIMEDEUVIMED entdecken
Crossref

Comparing Lisinopril and Telmisartan on Renal Function in Diabetes Type 2 and Hypertensive Patients

Osamah Abdullah Hasan, Fadhel Abbas Al-hammami, Ahmed Mohammed Abdullah, Rasool Khalid Mohammed, Anowar Suhad Waad

International Academic Research Journal of Internal Medicine and Public Health · 13.09.2024 · 5 (2) · 1-6

DOI: 10.47310/iarjimph.2024.v05i02.09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Academic Research Journal of Internal Medicine and Public Health, online erschienen am 13.09.2024. Verfasst von Osamah Abdullah Hasan und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes is a non-communicable and severe disease sometimes referred to as a "silent killer." Hypertension often occurs alongside renal issues, and both hurt the kidneys. They are a primary factor in the development of cardiovascular problems and immune and nervous system issues. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play a role in the development of cardiovascular and renal problems in individuals with diabetes and hypertension.

Aim

The study examines the impact of lisinopril versus telmisartan on creatinine, urea, and uric acid levels in newly diagnosed hypertensive diabetic patients. methodology: The study followed a randomized controlled comparative trial format for seven months. Forty-three patients were treated with lisinopril and 39 with telmisartan. All patients were using the medication glibenclamide. Forty-eight healthy individuals were selected as controls. Enzymatic, colorimetric, and uricase methods were utilized to test serum creatinine, urea, and uric acid.

Results

Research findings indicate that diabetic patients undergoing treatment with Lisinopril experienced a notable reduction in blood creatinine levels. In contrast, individuals treated with telmisartan saw a considerable decline in serum urea levels but a significant rise in uric acid levels.

Conclusion

Lisinopril may be more effective than telmisartan in preserving renal function.

Zitieren

APA

Hasan, O. A., Al-hammami, F. A., Abdullah, A. M., Mohammed, R. K., & Waad, A. S. (2024). Comparing Lisinopril and Telmisartan on Renal Function in Diabetes Type 2 and Hypertensive Patients. International Academic Research Journal of Internal Medicine and Public Health, 5(2), 1-6. https://doi.org/10.47310/iarjimph.2024.v05i02.09

Vancouver

Hasan OA, Al-hammami FA, Abdullah AM, Mohammed RK, Waad AS. Comparing Lisinopril and Telmisartan on Renal Function in Diabetes Type 2 and Hypertensive Patients. International Academic Research Journal of Internal Medicine and Public Health. 2024;5(2):1-6. doi:10.47310/iarjimph.2024.v05i02.09

BibTeX
@article{Hasan2024,
  author = {Hasan, Osamah Abdullah and Al-hammami, Fadhel Abbas and Abdullah, Ahmed Mohammed and Mohammed, Rasool Khalid and Waad, Anowar Suhad},
  title = {Comparing Lisinopril and Telmisartan on Renal Function in Diabetes Type 2 and Hypertensive Patients},
  journal = {International Academic Research Journal of Internal Medicine and Public Health},
  year = {2024},
  volume = {5},
  number = {2},
  pages = {1--6},
  doi = {10.47310/iarjimph.2024.v05i02.09}
}
Kostenlos starten →